NEOTHYLLINE Drug Patent Profile
✉ Email this page to a colleague
When do Neothylline patents expire, and when can generic versions of Neothylline launch?
Neothylline is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in NEOTHYLLINE is dyphylline. There are two drug master file entries for this compound. Additional details are available on the dyphylline profile page.
Summary for NEOTHYLLINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 3,573 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NEOTHYLLINE at DailyMed |
US Patents and Regulatory Information for NEOTHYLLINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | NEOTHYLLINE | dyphylline | ELIXIR;ORAL | 007794-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | NEOTHYLLINE | dyphylline | TABLET;ORAL | 007794-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | NEOTHYLLINE | dyphylline | INJECTABLE;INJECTION | 009088-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |